TTK and breast carcinoma: In addition, basal breast cancer cell lines, some of which are also PTEN-deficient, showed higher sensitivity to cell death upon MPS1 inhibition in comparison to luminal breast cancers, indicating a potential patient stratification for treatment with an MPS1 inhibitor.